Beta

Myomo, inc.MYO.US Overview

US StockHealthcare
(No presentation for MYO)
OverviewAI AnalysisFinancialsFinancial ForecastStock SentimentalInstitutionsTradingView Chart

Ticker

Value

empty

There is no following symbol in this watchlist.

MYO AI Insights

MYO Overall Performance

MYO AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

MYO Recent Performance

-1.20%

Myomo, inc.

-1.10%

Avg of Sector

-0.49%

S&P500

MYO PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

Check MYO's Trend

MYO Key Information

MYO Valuation Metrics

MYO Profile

Myomo, Inc., a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living. Its products are designed to help improve function in adults and adolescents with neuromuscular conditions due to brachial plexus injury, stroke, traumatic brain injury, spinal cord injury, and other neurological disorders. The company sells its products to orthotics and prosthetics providers, the Veterans Health Administration, and rehabilitation hospitals, as well as through distributors. Myomo, Inc. was incorporated in 2004 and is headquartered in Boston, Massachusetts.

Price of MYO

MYO FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

MYO Earnings Table

Unit : USD

QTRNon-GAAP EPSEPS YoYEPS Surprise %SalesSales YoYSales Surprise %NPM
Current
2025Q4
2025Q3
2025Q2
2025Q1
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-0.40
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
0.78
PB Ratio
2.78
Price-to-FCF
-
METRIC
VALUE
vs. INDUSTRY
Gross Margin
65.70%
Net Margin
-38.05%
Revenue Growth (YoY)
25.73%
Profit Growth (YoY)
15.97%
3-Year Revenue Growth
41.10%
3-Year Profit Growth
43.62%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
-0.40
PE Ratio (TTM)
-
Forward PE
-
PS Ratio (TTM)
0.78
PB Ratio
2.78
Price-to-FCF
-
Gross Margin
65.70%
Net Margin
-38.05%
Revenue Growth (YoY)
25.73%
Profit Growth (YoY)
15.97%
3-Year Revenue Growth
41.10%
3-Year Profit Growth
43.62%
  • When is MYO's latest earnings report released?

    The most recent financial report for Myomo, inc. (MYO) covers the period of 2025Q4 and was published on 2025/12/31. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating MYO's short-term business performance and financial health. For the latest updates on MYO's earnings releases, visit this page regularly.

  • What is the operating profit of MYO?

    According to the latest financial report, Myomo, inc. (MYO) reported an Operating Profit of -2.77M with an Operating Margin of -24.43% this period, representing a decline of 1,030.7% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.

  • How is MYO's revenue growth?

    In the latest financial report, Myomo, inc. (MYO) announced revenue of 11.35M, with a Year-Over-Year growth rate of -5.93%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.

  • How much debt does MYO have?

    As of the end of the reporting period, Myomo, inc. (MYO) had total debt of 19.38M, with a debt ratio of 0.5. Long-term debt comprises a higher/lower proportion. The level of financial leverage directly impacts the company's capital structure and interest coverage. If debt is high, pay attention to interest expenses and refinancing risks. Conversely, a low-leverage structure indicates greater risk tolerance but potentially less growth flexibility.

  • How much cash does MYO have?

    At the end of the period, Myomo, inc. (MYO) held Total Cash and Cash Equivalents of 14.71M, accounting for 0.38 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Does MYO go with three margins increasing?

    In the latest report, Myomo, inc. (MYO) did not achieve the “three margins increasing” benchmark, with a gross margin of 68.6%%, operating margin of -24.43%%, and net margin of -33.6%%. This demonstrates limited improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess MYO's profit trajectory and future growth potential.

  • What is the FCF of MYO?

    Myomo, inc. (MYO)'s Free Cash Flow (FCF) for the period is -1.49M, calculated as Operating Cash Flow minus Capital Expenditures, representing a fall of 159.58% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.

  • What are the PEG ratio and PE ratio of MYO?

    The latest valuation data shows Myomo, inc. (MYO) has a Price-To-Earnings (PE) ratio of -2.01 and a Price/Earnings-To-Growth (PEG) ratio of -5.62. A PEG below 1 usually suggests the market is underestimating growth potential, while a PEG above 1 indicates high growth expectations are already priced in. Investors should conduct a comprehensive valuation by considering historical growth, market forecasts, and industry cycles.